N@N

Angiotech';s licensee, Cook Medical, announces single-arm study reveals 86.2 percent SFA vessel patency for Zilver(R) PTX(TM)

^{Published on 2010-05-25 11:10:16 - Market Wire}
 

 The single-arm study also revealed: - A low stent fracture rate of just 1.5 per cent - On average a greater than 50 per cent reduction in restenosis compared to published studies on bare-metal and other drug-eluting stents(2) - Improved clinical outcomes at 12 months according to all four key clinical indicators (ABI, Rutherford Score, walking speed and walking distance) 

 ------------------------- (1) Doppler tests (utilising PVSR less than 2.5) at 12 month check-up confirmed that the patient's vessel remained open in 86.2 per cent of cases (2) FAST: [ www.vascularweb.org/Annual_Meeting/Abstracts/2006/Bosiers_The_Femoral_Artery_S ] tenting_Trial_.html Durability: [ www.clinicaltrials.gov/ct2/show/NCT00530712?term=DURABILITY+II&rank=1 ] Absolute: [ www.clinicaltrials.gov/ct2/show/NCT00180505?term=absolute&cond=peripheral+arte ] rial+disease&cntry1=EU%3ABE&rank=2 STRIDES: [ www.clinicaltrials.gov/ct2/show/NCT00475566?term=STRIDES+%2B+lammer&rank=1 ]